{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T13:47:21Z","timestamp":1784036841263,"version":"3.55.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7]]},"abstract":"<jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>To assess the etiologies and outcomes of patients with secondary hemophagocytic lymphohistiocytosis in the PICU.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design:<\/jats:title>\n            <jats:p>Prospective observational cohort study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Setting:<\/jats:title>\n            <jats:p>A single PICU at a pediatric tertiary hospital in Hanoi, Vietnam.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients:<\/jats:title>\n            <jats:p>Pediatric patients meeting the criteria for secondary hemophagocytic lymphohistiocytosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>None.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Measurements and Main Results:<\/jats:title>\n            <jats:p>Between June 2017 and May 2018, 25 consecutive patients with a mean (<jats:sc>sd<\/jats:sc>) age of 23.3 months (21.6 mo) were included. Collected variables included etiologies of hemophagocytic lymphohistiocytosis and clinical and laboratory findings at admission. The Pediatric Index of Mortality 2 score at admission was calculated. Outcomes were death and multiple organ dysfunction. The severity of multiple organ dysfunction was assessed by the Pediatric Logistic Organ Dysfunction 2 score. The mean (<jats:sc>sd<\/jats:sc>) Pediatric Index of Mortality 2 predicted mortality rate was 5.6% (7.6%). Cytomegalovirus and Epstein-Barr virus coinfections (60%) were the most common suspected etiology of hemophagocytic lymphohistiocytosis. Other etiologies included Epstein-Barr virus sole infections (20%), cytomegalovirus sole infections (16%), and one unknown cause (4%). Multiple organ dysfunction (excluding hematologic failure) was found in 22 patients (88%) with death occurring in 14 patients (56%). The mean (<jats:sc>sd<\/jats:sc>) Pediatric Logistic Organ Dysfunction 2 predicted mortality rate among patients with multiple organ dysfunction was 11.9% (11.2%). Despite having lower Pediatric Index of Mortality 2 predicted mortality rates at admission, Epstein-Barr virus-cytomegalovirus coinfection cases with multiple organ dysfunction had slightly greater Pediatric Logistic Organ Dysfunction 2 predicted mortality rates than Epstein-Barr virus sole infection cases with multiple organ dysfunction: 12.2% (10.5%) versus 11.3% (11.0%). However, these rates were lower than cytomegalovirus sole infection cases with multiple organ dysfunction (14.4% [16.3%]). Area under the curve values for Pediatric Index of Mortality 2 and Pediatric Logistic Organ Dysfunction 2 were 0.74 (95% CI, 0.52\u20130.95) and 0.78 (95% CI, 0.52\u20131.00), respectively, suggesting that both scales were fair to good at predicting mortality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Viral infections, particularly Epstein-Barr virus-cytomegalovirus coinfections, were a common cause of secondary hemophagocytic lymphohistiocytosis. The implication of these coinfections on the clinical course of hemophagocytic lymphohistiocytosis needs to be delineated.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/pcc.0000000000001980","type":"journal-article","created":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T03:28:49Z","timestamp":1559273329000},"page":"e311-e318","source":"Crossref","is-referenced-by-count":14,"title":["Etiologies and Clinical Outcomes of Patients With Secondary Hemophagocytic Lymphohistiocytosis at a Tertiary PICU"],"prefix":"10.1097","volume":"20","author":[{"given":"Dyda","family":"Dao","sequence":"first","affiliation":[{"name":"Mayo Clinic College of Medicine and Science, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tran D.","family":"Xoay","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, National Hospital of Pediatrics, Hanoi, Vietnam."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda K.","family":"Galeano","sequence":"additional","affiliation":[{"name":"Mayo Clinic College of Medicine and Science, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phan H.","family":"Phuc","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, National Hospital of Pediatrics, Hanoi, Vietnam."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Ouellette","sequence":"additional","affiliation":[{"name":"Division of Pediatric Critical Care Medicine, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230823","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bcmd.2016.10.023","article-title":"Recent advances in diagnostic and therapeutic guidelines for primary and secondary hemophagocytic lymphohistiocytosis.","volume":"64","author":"Ramachandran","year":"2017","journal-title":"Blood Cells Mol Dis"},{"key":"R2-20230823","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2141.2007.06922.x","article-title":"Frequency and spectrum of central nervous system involvement in 193 children with haemophagocytic lymphohistiocytosis.","volume":"140","author":"Horne","year":"2008","journal-title":"Br J Haematol"},{"key":"R3-20230823","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/ped.13064","article-title":"Hemophagocytic lymphohistiocytosis: Pathogenesis, diagnosis, and management.","volume":"58","author":"Morimoto","year":"2016","journal-title":"Pediatr Int"},{"key":"R4-20230823","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s13054-016-1369-3","article-title":"Your critical care patient may have HLH (hemophagocytic lymphohistiocytosis).","volume":"20","author":"Machowicz","year":"2016","journal-title":"Crit Care"},{"key":"R5-20230823","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"R6-20230823","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s00134-008-1111-y","article-title":"Understanding organ dysfunction in hemophagocytic lymphohistiocytosis.","volume":"34","author":"Cr\u00e9put","year":"2008","journal-title":"Intensive Care Med"},{"key":"R7-20230823","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1182\/blood-2011-06-356261","article-title":"Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: Long-term results of the HLH-94 treatment protocol.","volume":"118","author":"Trottestam","year":"2011","journal-title":"Blood"},{"key":"R8-20230823","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s00134-002-1601-2","article-title":"PIM2: A revised version of the paediatric index of mortality.","volume":"29","author":"Slater","year":"2003","journal-title":"Intensive Care Med"},{"key":"R9-20230823","first-page":"e030254","article-title":"Multiple organ failure in the newborn.","volume":"3","author":"Aufieri","year":"2014","journal-title":"J Pediatr Neonat Individual Med"},{"key":"R10-20230823","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13613-016-0144-6","article-title":"Multiple organ dysfunction syndrome in critically ill children: Clinical value of two lists of diagnostic criteria.","volume":"6","author":"Villeneuve","year":"2016","journal-title":"Ann Intensive Care"},{"key":"R11-20230823","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1097\/CCM.0b013e31828a2bbd","article-title":"PELOD-2: An update of the PEdiatric logistic organ dysfunction score.","volume":"41","author":"Leteurtre","year":"2013","journal-title":"Crit Care Med"},{"key":"R12-20230823","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3109\/08880018.2013.858198","article-title":"Risk factors for early fatal outcomes among children with hemophagocytic lymphohistiocytosis (HLH): A single-institution case-series in Vietnam.","volume":"31","author":"Dao","year":"2014","journal-title":"Pediatr Hematol Oncol"},{"key":"R13-20230823","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s13312-011-0020-2","article-title":"Profile of hemophagocytic lymphohistiocytosis in children in a tertiary care hospital in India.","volume":"48","author":"Ramachandran","year":"2011","journal-title":"Indian Pediatr"},{"key":"R14-20230823","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1097\/MPH.0b013e31822d4ea7","article-title":"Prevalence of coinfection in children with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.","volume":"34","author":"Qiang","year":"2012","journal-title":"J Pediatr Hematol Oncol"},{"key":"R15-20230823","first-page":"157","article-title":"Hemophagocytic syndrome: A review of 18 pediatric cases.","volume":"37","author":"Chen","year":"2004","journal-title":"J Microbiol Immunol Infect"},{"key":"R16-20230823","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1348-0421.2007.tb03890.x","article-title":"Virological and immunological characteristics of fatal virus-associated haemophagocytic syndrome (VAHS).","volume":"51","author":"Kashiwagi","year":"2007","journal-title":"Microbiol Immunol"},{"key":"R17-20230823","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2141.2009.07957.x","article-title":"Comprehensive analyses and characterization of haemophagocytic lymphohistiocytosis in Vietnamese children.","volume":"148","author":"My","year":"2010","journal-title":"Br J Haematol"},{"key":"R18-20230823","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/S0046-8177(98)90416-6","article-title":"Polymerase chain reaction amplification of archival material for Epstein-Barr virus, cytomegalovirus, human herpesvirus 6, and parvovirus B19 in children with bone marrow hemophagocytosis.","volume":"29","author":"Hoang","year":"1998","journal-title":"Hum Pathol"},{"key":"R19-20230823","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/cid\/cit018","article-title":"Long-term outcomes of congenital cytomegalovirus infection in Sweden and the United Kingdom.","volume":"56","author":"Townsend","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R20-20230823","doi-asserted-by":"crossref","first-page":"625","DOI":"10.5694\/j.1326-5377.2011.tb03144.x","article-title":"Congenital cytomegalovirus\u2013time to diagnosis, management and clinical sequelae in Australia: Opportunities for earlier identification.","volume":"194","author":"McMullan","year":"2011","journal-title":"Med J Aust"},{"key":"R21-20230823","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/jmv.21527","article-title":"Cytomegalovirus and Epstein-Barr virus coinfection in three toddlers with prolonged illnesses.","volume":"81","author":"Ito","year":"2009","journal-title":"J Med Virol"},{"key":"R22-20230823","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/1743-422X-7-247","article-title":"Coinfection with EBV\/CMV and other respiratory agents in children with suspected infectious mononucleosis.","volume":"7","author":"Wang","year":"2010","journal-title":"Virol J"},{"key":"R23-20230823","first-page":"242","article-title":"Mononucleosis syndromes with serology doubly positive to Epstein-Barr virus and cytomegalovirus.","volume":"45","author":"S\u00e1nchez","year":"1996","journal-title":"An Esp Pediatr"},{"key":"R24-20230823","doi-asserted-by":"crossref","first-page":"e6431","DOI":"10.1097\/MD.0000000000006431","article-title":"Comparison of the pediatric risk of mortality, pediatric index of mortality, and pediatric index of mortality 2 models in a pediatric intensive care unit in China: A validation study.","volume":"96","author":"Qiu","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"R25-20230823","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s12098-010-0031-3","article-title":"Performance of PRISM (Pediatric Risk of Mortality) score and PIM (Pediatric Index of Mortality) score in a tertiary care pediatric ICU.","volume":"77","author":"Taori","year":"2010","journal-title":"Indian J Pediatr"},{"key":"R26-20230823","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/tropej\/50.6.334","article-title":"The comparison of PRISM and PIM scoring systems for mortality risk in infantile intensive care.","volume":"50","author":"Ozer","year":"2004","journal-title":"J Trop Pediatr"},{"key":"R27-20230823","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00431-017-2916-x","article-title":"Performance of the pediatric logistic organ dysfunction (PELOD) and (PELOD-2) scores in a pediatric intensive care unit of a developing country.","volume":"176","author":"El-Nawawy","year":"2017","journal-title":"Eur J Pediatr"},{"key":"R28-20230823","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2017.03.023","article-title":"Similar but not the same: Differential diagnosis of HLH and sepsis.","volume":"114","author":"Machowicz","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"key":"R29-20230823","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.18203\/2349-3291.ijcp20172700","article-title":"A HLH is a rare fatal condition easily misdiagnosed as infectious disease.","volume":"4","author":"Moinuddin","year":"2017","journal-title":"Int J Contemp Pediatr"},{"key":"R30-20230823","first-page":"254","article-title":"Atypical Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis simulating lymphadenitis on 18F-FDG PET\/CT and its differential diagnosis.","volume":"20","author":"Lu","year":"2017","journal-title":"Hell J Nucl Med"},{"key":"R31-20230823","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1111\/apa.13226","article-title":"Extremely elevated C-reactive protein levels are associated with unfavourable outcomes, including death, in paediatric patients.","volume":"105","author":"Pasternak","year":"2016","journal-title":"Acta Paediatr"},{"key":"R32-20230823","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/j.jpedsurg.2004.08.002","article-title":"C-Reactive protein-determined injury severity: Length of stay predictor in surgical infants.","volume":"39","author":"Alaedeen","year":"2004","journal-title":"J Pediatr Surg"},{"key":"R33-20230823","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/INF.0b013e3181b9a086","article-title":"Predicting severe bacterial infections in well-appearing febrile neonates: Laboratory markers accuracy and duration of fever.","volume":"29","author":"Bressan","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"R34-20230823","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1378\/chest.123.6.2043","article-title":"C-reactive protein levels correlate with mortality and organ failure in critically ill patients.","volume":"123","author":"Lobo","year":"2003","journal-title":"Chest"},{"key":"R35-20230823","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.1097\/PCC.0b013e31820abca8","article-title":"Very high serum ferritin levels are associated with increased mortality and critical care in pediatric patients.","volume":"12","author":"Bennett","year":"2011","journal-title":"Pediatr Crit Care Med"},{"key":"R36-20230823","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/pbc.22774","article-title":"Rate of decline of ferritin in patients with hemophagocytic lymphohistiocytosis as a prognostic variable for mortality.","volume":"56","author":"Lin","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"R37-20230823","doi-asserted-by":"crossref","first-page":"e176","DOI":"10.1097\/PCC.0b013e3182720f94","article-title":"Severe hemorrhagic coagulopathy with hemophagocytic lymphohistiocytosis secondary to Epstein-Barr virus-associated T-cell lymphoproliferative disorder.","volume":"14","author":"Nawathe","year":"2013","journal-title":"Pediatr Crit Care Med"}],"container-title":["Pediatric Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00130478-201907000-00031","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:49:14Z","timestamp":1692838154000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00130478-201907000-00031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/pcc.0000000000001980","relation":{},"ISSN":["1529-7535"],"issn-type":[{"value":"1529-7535","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]}}}